QYR in News

Beijing Stock Exchange IPO Report: Puang Medical: A “Little Giant” in Infusion and Puncture Devices with a Top-3 Global Market Share, Driven by Insulin Pen Needles and Minimally Invasive Interventions

According to QYResearch data, the global insulin pen needle market was valued at $1.35 billion in 2024 and is projected to reach $1.99 billion by 2031, with a CAGR of 5.8%; the Chinese market is valued at $194 million; The global blood collection needle market is projected to reach $1.674 billion in 2024, with the Chinese market at $181 million.

Source: Securities Star

More: http://stock.stockstar.com/JC2026031700033173.shtml